TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹14,396 Cr | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr | ₹13,653 Cr |
What is the latest Total Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹14,396 Cr |
| Mar2024 | ₹14,505 Cr |
| Mar2023 | ₹14,468 Cr |
| Mar2022 | ₹12,606 Cr |
| Mar2021 | ₹13,653 Cr |
How is Total Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14,396 Cr | -0.76 | |
| Mar2024 | ₹14,505 Cr | 0.26 | |
| Mar2023 | ₹14,468 Cr | 14.77 | |
| Mar2022 | ₹12,606 Cr | -7.67 | |
| Mar2021 | ₹13,653 Cr | - | |
Compare Total Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹121,040.6 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
| MANKIND PHARMA | ₹97,796.9 Cr | -3.1% | -3.3% | -8.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.6% |
1.8% |
15.7% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses